Acute ischemic stroke refers
to a sudden loss of certain brain function owing to uneven or lack of blood to
the brain. Acute ischemic functions are mainly triggered by atherosclerosis plaques
blocking blood vessels, blood clots locking the blood distribution to or from
arteries nourishing the brain, or narrowing of blood vessels of the brain. Acute
ischemic stroke is one of the major causes of permanent disability in the
patients. It is also the third largest reason of death worldwide. Acute ischemic
stroke can affect persons of all age groups. However, acute ischemic stroke
most commonly affects the individuals, who are above 60 years, the risk of
acute ischemic stroke increases with age. Driven by the technical advancement
in diagnosis, the acute ischemic stroke diagnosis and treatment demand is
expected to experience an escalating demand in coming years.
To
know more visit:
https://www.psmarketresearch.com/market-analysis/acute-ischemic-stroke-diagnosis-and-treatment-market
The advancements in the surgical
devices technology, in addition with the rising occurrence of acute ischemia
stroke cases among the patients are some of the dominant driving factor for the
surgery in acute stroke treatment. Some of the other factors driving the market
include, aging population mainly in the developed countries of Europe and North
America. The development of the effective medication in the treatment of
ischemic stroke is accepted to hinder the acceptance of expensive surgery in
the ischemic stroke diagnosis market. The development of desmoteplase, a novel
next-generation thrombolytic, is one of the major advancement of in the
treatment technology of acute ischemic stroke. It provides extended therapeutic
time compared to most of the other treatment procedure. Moreover, with the increasing
impact of telemedicine and e-prescription and e-medical adherence the acute ischemic stroke diagnosis and
treatment market
is expected to flourish at a healthy rate during the forecast period.
Request for Table of Content: https://www.psmarketresearch.com/market-analysis/Acute-Ischemic-Stroke-Diagnosis-and-Treatment-Market/toc-sample
The major hindrance in the
development of acute ischemic stroke diagnosis and treatment market is in the
clinical trial, which include long testing of drug after stroke onset, in
addition to insufficient selection of patients for the trials.
Some of the leading players
operating in global acute ischemic stroke diagnosis and treatment market include, Abbott Laboratories, Covidien
plc, Johnson & Johnson (Cordis Corporation), Penumbra, Inc., Philips
Healthcare, GE Healthcare, Hitachi, Ltd., Siemens Healthcare, and Stryker
Corporation (Concentric Medical, Inc.)
About P&S
Market Research
P&S Market Research is
a global market research and consulting company. We provide market research
reports, industry reports, business intelligence and research based consulting
services across a range of industries.
With the help of our
professional corporate relations with various companies, our market research
offers the most accurate market forecasting. Our analysts and consultants
interact with leading companies of the concerned domain to substantiate every
single data presented in our publication.
Our research assists our client in identifying new and different windows
of opportunity and frame informed and customized strategies for expansion in
different regions.
Contact:
Abhishek
Executive –
Client Partner
347, 5th
Ave. #1402
New York
City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Web: https://www.psmarketresearch.com
No comments:
Post a Comment